13F-HR - FELL CAPITAL MANAGEMENT /ADV (0000850601) (Filer)
Institutional holdings report (13F-HR) filed by FELL CAPITAL MANAGEMENT /ADV.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Institutional holdings report (13F-HR) filed by FELL CAPITAL MANAGEMENT /ADV.
Algorhythm Holdings extended and amended the employment agreement with CEO Gary Atkinson. The updated agreement sets a new Term starting February 23, 2026. These leadership changes…
Institutional holdings report (13F-HR) filed by Tenon Financial LLC.
Institutional holdings report (13F-HR) filed by SURIENCE PRIVATE WEALTH LLC.
Institutional holdings report (13F-HR) filed by Penobscot Investment Management Company, Inc..
Institutional holdings report (13F-HR) filed by L.K. Benson & Company, P.C..
Institutional holdings report (13F-HR) filed by Vest Financial, LLC.
Institutional holdings report (13F-HR) filed by Beta Wealth Group, Inc..
Institutional holdings report (13F-HR) filed by Conestoga Capital Advisors, LLC.
Travelers Companies Inc. issued $750 million in 4.950% senior notes maturing in 2031 through an underwriting agreement.
QVC Group, Inc. has filed a Second Amended Joint Prepackaged Plan of Reorganization with the U.S. Bankruptcy Court. This restructuring action follows solicitation and involves coll…
Institutional holdings report (13F-HR) filed by Tower View Wealth Management LLC.
QVC Group has filed a second amended joint prepackaged plan of reorganization with the U.S. Bankruptcy Court in Houston. This follows an extensive solicitation process and is inten…
Braemar Hotels & Resorts Inc. declared preferred stock dividends varying from $0.17708 to $0.5156 per share, scheduled for payment in late September and October 2026.
Outlook Therapeutics received FDA approval for LYTENAVA (bevacizumab-vikg), the first ophthalmic formulation of bevacizumab, targeting a significant portion of the wet AMD market.
Institutional holdings report (13F-HR) filed by CPC Advisors, LLC.
Institutional holdings report (13F-HR) filed by Avidian Wealth Enterprises, LLC.
Institutional holdings report (13F-HR) filed by Transce3nd, LLC.
Institutional holdings report (13F-HR) filed by Whelan Financial.
Allurion Technologies exchanged an aggregate of 392,766 shares of common stock for pre-funded common stock warrants on July 21, 2026. The transaction is exempt from registration un…